New Novartis R&D centre in China
Fabrice Martin
Swiss pharmaceutical lab company Novartis announced its 8th R&D centre in Shanghaï, China.Mainly dedicated to research on infectious causes of prevalent cancers in China, this centre represents a USD 100 million investment. By establishing its new centre, which should employ more than 400 researchers by 2008, at the Zhangjiang Hi-Tech Park, near Shanghaï, Novartis bets on the development of this emerging life science cluster.
Operations are set to begin in May 2007.
More information about ABG?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
Groupe AFNOR - Association française de normalisation
SUEZ
Institut Sup'biotech de Paris
MabDesign
CESI
Aérocentre, Pôle d'excellence régional
TotalEnergies
Généthon
ONERA - The French Aerospace Lab
MabDesign
ASNR - Autorité de sûreté nucléaire et de radioprotection - Siège
CASDEN
Laboratoire National de Métrologie et d'Essais - LNE
Ifremer
ANRT
Tecknowmetrix
PhDOOC
Nokia Bell Labs France
ADEME
-
Thesis topicRef. 130247, Nouvelle Aquitaine , FrancePprime / EIGSI
Mesure et modélisation des déformations sur une batterie pendant des cycles de charge / décharg
Scientific expertises :Engineering sciences
-
JobRef. 129435, Ile-de-France , FranceOWI
Ingénieur R&D en Machine Learning
Scientific expertises :Computer science
Experience level :Confirmed